A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog® in Patients With T1DM
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 04 Dec 2017 Planned End Date changed from 1 May 2018 to 1 Mar 2018.
- 04 Dec 2017 Planned primary completion date changed from 1 May 2018 to 1 Mar 2018.
- 17 Nov 2017 New trial record